Results 1 to 10 of about 29,315 (207)
FONDAPARINUX USAGE IN NON-ST-ELEVATION ACUTE CORONARY SYNDROME
Российский кардиологический журнал, 2015 Anticoagulation treatment is a vital component of acute coronary syndrome treatment. Selection of the most efficient and safe drug for the acute coronary syndrome patients without ST elevation (NSTEACS) depends on the strategy of treatment and is in fact
G. V. Mardaryan, S. A. Abugov
doaj +1 more source
Interventional radiology treatments for iatrogenic severe bleeding during percutaneous coronary interventions [PDF]
, 2018 Purpose: Interventional cardiology and interventional radiology are separate medical disciplines in which intra-arterial contrast media are used. Interventional cardiology has resigned from many types of treatment techniques that are now used and ...
Brzozowski, Krzysztof +5 more
core +1 more source
Arquivos Brasileiros de Cardiologia, 2012 FUNDAMENTO: O uso combinado de agentes antitrombínicos, antiplaquetários e estratégias invasivas na síndrome coronariana aguda sem supradesnivelamento do ST (SCAsSST) reduz eventos cardiovasculares. O fondaparinux demonstrou equivalência à enoxaparina na
Camila Pepe +3 more
doaj
Cibles des médicaments antithrombotiques [PDF]
, 2006 Pour la quasi-totalité des classes thérapeutiques antithrombotiques actuellement utilisées et à venir, le ciblage a été initialement la conséquence d’une observation et non pas le fruit d’une recherche méthodique scientifique.
Drouet, Ludovic, Ripoll, Laurent
core +1 more source
ANGINA INESTABLE. PROPUESTA DE PROTOCOLO DE TRATAMIENTO EN EL HOSPITAL [PDF]
, 2010 Unstable angina is an acute coronary syndrome without elevation of the ST segment. It is clinically important because of its threatening and crippling nature, due to the possibility that it could precede acute myocardial infarction.
Leonel Hernández Cruz +2 more
core
Prevention of venous thromboembolism after hip and knee replacement among older adults [PDF]
, 2017 BACKGROUND: Venous thromboembolism (VTE) after total hip and knee replacement is a major patient safety threat, and pharmacologic prophylaxis is generally recommended. However, clinicians disagree on the optimal prophylaxis agent.
Ko, Darae
core
Investigação recente em antitrombóticos. Novidades para o tratamento dos doentes com síndromas coronárias agudas [PDF]
, 2010 A terapêutica antitrombótica ocupa um lugar central no tratamento da doença coronária aguda. A sua importância foi reforçada com a generalização dos procedimentos de intervenção percutânea, em especial quando são implantados dispositivos intra-coronários.
Morais, João
core
Evaluation of bleeding risk in patients with renal impairment treated with Fondaparinux (Arixtra)
Journal of Applied Hematology, 2016 Background: Fondaparinux (Arixtra) a synthetic pentasaccharide that causes an antithrombin III-mediated selective inhibition of factor Xa. The clearance of fondaparinux reduces in patients with renal impairment, and there are no dosage adjustments ...
Hend H Metwali +6 more
doaj +1 more source
BMC SurgeryObjectives To compare the efficacy of nadroparin and fondaparinux sodium for prevention of deep vein thromboembolism (DVT) in lower extremities after total hip arthroplasty (THA) and total knee arthroplasty (TKA).
Xiang Gao +5 more
doaj +1 more source
Antiagregación y anticoagulación en síndromes coronarios agudos: niveles de evidencia [PDF]
, 2007 Management of acute coronary syndromes (ACS) has moved rapidly in parallel with our understanding of the pathophysiological basis of the disease. In the eighties, the demonstration of the pivotal role of coronary thrombosis in the etiology of a ACS led ...
Garcia, R. (R.) +3 more
core